Nusrath Zuha
Ketamine, described by the formula C13H16ClNO, is most ordinarily related to adolescent and adult narcotic users and ravers who abuse this drug to experience a euphoric and dissociative state. Although this drug may be a federal schedule III drug as a results of this abuse potential, ketamine has experienced a renaissance in clinical interest in recent years.1 Although clinical use of ketamine is controversial, it's become a focus of pharmacological research thanks to its considerably diverse molecular targets and neurophysiological properties.2 In fact, recent studies have cited ketamine as a possible therapy for depression, including treatment resistant varieties, also as alcohol use disorders
